Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | ZYDUSLIFE Zydus Lifesciences Limited Pharma · Large | LUPIN Lupin Limited Pharma · Mid | DIVISLAB Divi's Laboratories Limited Pharma · Large | AJANTPHARM Ajanta Pharma Limited Pharma · Large |
|---|---|---|---|---|
| Final Score | 63 | 79 | 42 | 54 |
| Verdict | UNDERVALUED | DEEP VALUE | WATCHLIST | FAIR VALUE |
| Style | Growth at Value | Top Setup | WATCHLIST | Premium Compounder |
| Piotroski | 8/9 | 8/9 | 8/9 | 8/9 |
| Valuation | 12/30 | 14/30 | 0/30 | 4/30 |
| Growth | 21/25 | 25/25 | 9/25 | 13/25 |
| Quality | 12/20 | 20/20 | 13/20 | 17/20 |
| Balance Sheet | 10/15 | 9/15 | 10/15 | 11/15 |
| Cash Flow | 4/10 | 6/10 | 5/10 | 4/10 |
| Price | ₹1,103.4 | ₹2,263 | ₹6,757 | ₹3,017.2 |
| P/E | 20.50 | 18.00 | 68.40 | 35.10 |
| P/B | 4.11 | 4.61 | 10.70 | 8.20 |
| ROE | 21.20% | 29.10% | 16.50% | 25.40% |
| ROCE | 21.20% | 30.30% | 22.00% | 32.30% |
| Debt / Equity | 0.46 | 0.29 | 0.00 | 0.06 |
| FCF Yield | — | 3.35% | 1.38% | 0.27% |
| Dividend Y | 0.09% | 0.53% | 0.44% | 0.94% |
| Altman Z | 4.60 | 6.42 | 8.56 | 8.92 |
| Promoter % | 75.00% | 46.85% | 51.88% | 66.25% |
| Mkt Cap (₹Cr) | 111265.00 | 103614.00 | 179399.00 | 37091.00 |
| Graham # | ₹550.61 | ₹1,135.21 | ₹1,171.89 | ₹829.71 |
| Fair PE | 42.0 | 42.0 | 16.1 | 42.3 |
| MoS % | +47.5% | +53.8% | -334.9% | +15.6% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startZYDUSLIFE114
LUPIN108
DIVISLAB113
AJANTPHARM105